French firm files EU antitrust motion against IBM – IBM using patents to prevent French company TurboHercules from offering an opensource emulator that would allow people to use certain IBM software without buying the mainframe to which it is tied.
Soos @ Guardian: Patents system has had its day – alternatives to pharma patents; “Dean Baker provides the most realistic answer: the government should directly perform the R&D as a public good and let firms produce medicines, as a private good, at competitive free-market prices.”
Item 31 could be an alternative to a unified patent litigation system:
NOTES the importance of simplifying the cross-border enforcement of judicial decisions in order to ensure an effective intellectual property rights protection; in this respect, asks the Commission and the Member States to consider how to support the review of the Brussels I Regulation (Council Regulation (EC) No 44/2001 of 22 December 2000 on jurisdiction and the recognition and enforcement of judgments in civil and commercial matters, OJ L 12, 16.1.2001, p. 1.)
In 2007 Battistelli, then president of the French Patent Office, killed EPLA, which was being championed by the EPO and was EPO-centric, and set the European Commission moving toward its present Union Patent Litigation System proposal which is more in line with EU law